Adverse Events After Drug Discontinuation: A Pharmacovigilance Framework for Distinguishing Withdrawal Syndromes, Rebound Effects, Disease Recurrence, and Delayed Treatment-Related Harm
International Journal of Pharmaceutical Research and Allied Sciences · 2026 · 15 (4) · 152-161
DOI: 10.51847/sg3umf1cxu ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Research and Allied Sciences, 2026. Verfasst von Sofia Marchetti und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Marchetti, S., Rahman, A., & Rossi, E. (2026). Adverse Events After Drug Discontinuation: A Pharmacovigilance Framework for Distinguishing Withdrawal Syndromes, Rebound Effects, Disease Recurrence, and Delayed Treatment-Related Harm. International Journal of Pharmaceutical Research and Allied Sciences, 15(4), 152-161. https://doi.org/10.51847/sg3umf1cxu
Vancouver
Marchetti S, Rahman A, Rossi E. Adverse Events After Drug Discontinuation: A Pharmacovigilance Framework for Distinguishing Withdrawal Syndromes, Rebound Effects, Disease Recurrence, and Delayed Treatment-Related Harm. International Journal of Pharmaceutical Research and Allied Sciences. 2026;15(4):152-161. doi:10.51847/sg3umf1cxu
BibTeX
@article{Marchetti2026,
author = {Marchetti, Sofia and Rahman, Aisha and Rossi, Elena},
title = {Adverse Events After Drug Discontinuation: A Pharmacovigilance Framework for Distinguishing Withdrawal Syndromes, Rebound Effects, Disease Recurrence, and Delayed Treatment-Related Harm},
journal = {International Journal of Pharmaceutical Research and Allied Sciences},
year = {2026},
volume = {15},
number = {4},
pages = {152--161},
doi = {10.51847/sg3umf1cxu}
}
EUVIMED